Phase 4 N=104 Pilot Study of Edaravone to Treat Acute Myocardial Infarction
Myocardial Infarction · Reperfusion Injury
Primary: Cardiac Death — 0; 0 events
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=87 Community Care for Croup (RCT)
Croup
Primary: Additional Health Care — 7; 2 percentage of participants — p=0.34
Phase 4 N=201 Evaluating the Efficacy of an Absorbent Foam Dressing Containing Silver (Mepilex Ag) Versus the Same Dressing Without Silver Used on Subjects With Venous Leg Ulcers or Mixed Ulcers
Venous Leg Ulcers · Mixed Leg Ulcers
Primary: Efficacy Will be Defined as Absolute Wound Size Reduction. — -4.65; -5.09 cm2
Phase 4 N=59 Application and Effectiveness Analysis of Internet-based Diabetes Prevention Program
Type 2 Diabetes
Primary: Incidence of Type 2 Diabetes Mellitus — 1; 1 participants
Phase 4 N=15 Sustiva Levels With Use of a Gel Capsule
HIV · HIV Infections
Primary: Serum Levels of Efavirenz — 5151.11; 4965.08 ng/mL
Phase 4 N=20 Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion
Branch Retinal Vein Occlusion
Primary: Change in ETDRS Best Corrected Visual Acuity From Baseline at 54 Weeks — 14 ETDRS letters
Phase 4 N=30 Effect of Preoperative Estrogen Treatment on Connective Tissues of the Pelvic Floor
Pelvic Organ Prolapse · Menopause
Primary: Vaginal Wall Composition: Epithelium (Intention to Treat) — 413.9; 314.1 microns — p=0.21
Phase 4 N=21 An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild and Moderate Hepatic Insufficiency and Healthy Volunteers
Hepatic Impairment
Primary: Cmax for Serum Deferiprone and Deferiprone 3-O-glucuronide — 49.00; 36.26; 35.94; 69.03 ug/mL
Phase 4 N=140 Propofol Administered by Gastroenterologists by Target Controlled Infusion Pump During Endoscopy
Sedation · Endoscopy
Primary: Endoscopist's Satisfaction (Visual Analog Scale) About Sedation — 93; 83; 98; 87 units on a scale
Phase 4 N=53 A 3 Way Cross-over Study Evaluating the Effects of ADOAIR Twice Daily Plus Tiotropium Bromide Once Daily Compared With the Individual Treatments of Japanese Subjects
Pulmonary Disease, Chronic Obstructive
Primary: Area Under the Curve Calculated From 0 to 4 Hours (AUC[0-4hr]) Specific Conductance (sGaw) After the Morning Dose of Study Medication at Day 28 of Each Treatment Period…
Phase 4 N=52 Trial of Nicotine Nasal Spray as an Aid for Smoking Cessation in Schizophrenia
Smoking Cessation · Schizophrenia
Primary: The Number of Subjects Who Quit Smoking From Weeks 5 to 8 — 3; 1 participants — p=0.632
Phase 4 N=100 Study of Two Different Starting Doses of Methotrexate When Starting Treatment in Rheumatoid Arthritis
Rheumatoid Arthritis
Primary: Mean Change in the DAS28-3 (Disease Activity Score Using 28 Joints and Using 3 Variables) - Difference Between This Score at 12 Weeks and This Score at Baseline — -0.47…
Phase 4 N=21 Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for Schizophrenia
Schizophrenia
Primary: Change in Alternative Beliefs Assessment — 14.05; 10.70 units on a scale
Phase 4 N=81 Effect of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Myocardial Perfusion Imaging · Myocardial Ischemia
Primary: Exercise-induced Perfusion Defect Size (PDS) Following Ranolazine and Placebo Treatment — 21.54; 20.87 percentage of myocardium — p=0.29
Phase 4 N=143 Effectiveness of Methylphenidate in Improving Cognition and Function in Older Adults With Depression
Depression
Primary: Hamilton Depression Rating Scale (HDRS) Maintained Scores at Week 16 — 18.3; 18.7; 19.8 units on a scale